InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+30.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Haddadin Yezan Munther, 董事. Insider active across 1 company, notably Outlook Therapeutics, Inc.. In total, 3 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €72k. History available since 2 December 2021. The latest transaction was filed on 28 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Haddadin Yezan Munther
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
1,881.711 股@ US$11.8224.4% 占其流量Common StockSEC:0001415889-24-009394:0
标准退出：2024年6月26日 (T+90)
29,743 股@ US$1.2946.5% 占其流量Common StockSEC:0001209191-22-053354:0
标准退出：2023年1月4日 (T+90)
10,000 股@ US$1.3917.0% 占其流量Common StockSEC:0001209191-21-067650:0
标准退出：2022年3月2日 (T+90)
3 条申报中的 3 条
About Haddadin Yezan Munther
Yezan Munther Haddadin is a Board Member at Outlook Therapeutics, Inc. As a board member, he plays a key role in the governance of the company. His experience and business acumen are essential in guiding strategic decisions and ensuring compliance with regulatory standards. He also contributes to overseeing the company's performance.
